pharmaceutical investing Alimera Sciences and Knight Therapeutics Announce Filing of New Drug Submission for Iluvien® in Canada
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS® (prednisone) Delayed-Release Tablets
Q BioMed Inc. Advisor and Mannin Research Inc CSO Dr Susan Quaggin Discusses Glaucoma and Man-01 with Eye on Vision Radio
EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation and Pain Post Cataract Surgery
FPX Nickel Announces Funding Contribution from Natural Resources Canada to Advance the Baptiste Nickel Project
SAGA Metals Expands Radar Ti-V-Fe Project Vision with Preliminary Metallurgical Insights and Major Exploration Milestones
